CytoDyn Inc. Registered Shares DL -,01

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

19.33%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

0.00 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.244 G0 Units
PRICE DETERMINATION TIME06/08/2026 / 02:16:28 PM
DAILY VOLUME (UNITS)17,241
DAILY HIGH / LOW0.290.242
PREV. DAY'S PRICE0.242 (06/05)
CHANGE DAY BEFORE
+0.00
0.83 %
52 WEEK HIGH / LOW0.378 (04/20)0.16 (12/29)
More Price Information

Key Figures (in EUR)

20272026202520242023
EARNINGS PER SHARE---0.00-0.05
DIVIDENDS PER SHARE---0.000.00
DIVIDEND YIELD IN %---0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO---190.00-
PRICE - BOOK RATIO-----
PRICE - SALES RATIO-----
PRICE - CASH FLOW RATIO-----
Further Key Figures

Master Data

WKN
A0YHA5
ISIN
US23283M1018
SYMBOL
296
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
CYTODYN INC. DL -,01
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-3.97 %
-3.20 %
15.24 %
0.83 %
-19.33 %
0.83 %
-86.23 %
27.37 %
HIGH0.310.380.380.380.380.452.120.38
LOW0.240.240.200.160.160.090.090.17
Dividend
per share
CYTODYN INC. DL -,01 does not deliver dividend information

Company profile

CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.